COVID-19: BioMaking Solutions – Dr. Brendan Manning, Sherlock Biosciences, “Rapid Development and EUA Approval of the Sherlock SARS-CoV-2 Nucleic Acid Test”
OnlineCRISPR-based diagnostic methods are poised to have a significant impact on global health, and now, with the first FDA-emergency authorized use of CRISPR technology, this impact is being brought directly...